Life ScienceCompany
Currax Pharmaceuticals M&A Summary
Currax Pharmaceuticals has acquired 2 companies, including 2 in the last 5 years.
Currax Pharmaceuticals’ largest acquisition to date was in 2019, when it acquired Pernix Therapeutics Holdings for $76M. Currax Pharmaceuticals has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
Currax Pharmaceuticals Business Overview
Where is Currax Pharmaceuticals headquartered?
Currax Pharmaceuticals is headquartered in Morristown, New Jersey.
What sector is Currax Pharmaceuticals in?
Currax Pharmaceuticals is a life science company.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 1